Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $16.63M.
ENTERPRISE VALUE (EV)
$16.63M
Grace Therapeutics, Inc.
Market Cap
$33.61M
Enterprise Value (EV)
$16.63M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $33.61M | $16.63M |
| Scilex Holding Company (SCLX)vs › | $33.63M | $128.62M |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | $6.42M |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.93M | $46.86M |
| Elutia Inc (ELUT)vs › | $34.35M | $25.24M |
| Nephros, Inc. (NEPH)vs › | $32.79M | $28.96M |
| HeartBeam, Inc. (BEAT)vs › | $32.42M | $23.69M |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | $28.09M |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | $28.88M |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | $48.03M |
Market Cap
$33.61M
Total Debt
$0.00
Cash
$16.98M
Enterprise Value
$16.63M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
